Impact of antivirals and emergence of drug resistance: HSV-2 epidemic control

AIDS Patient Care and STDs

Volumn 14, Issue 3, 2000, Pages 133-142

  Gershengorn, H B ^a   Blower, S M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ANTIBIOTIC SENSITIVITY; DRUG EFFICACY; EPIDEMIC; GENITAL HERPES; HEALTH CARE POLICY; HERPES SIMPLEX VIRUS 2; INFECTION CONTROL; MATHEMATICAL MODEL; NONHUMAN; REVIEW; VIRUS SHEDDING;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CALIFORNIA; DISEASE OUTBREAKS; DRUG RESISTANCE, MICROBIAL; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MODELS, STATISTICAL; RISK FACTORS;

EID: 0034029866     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/108729100317911     Document Type: Review

References (23)

1. Fleming DT, McQuillan GM, Johnson, RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997;337:1105-1111.
2. Nahmias AJ, Lee FK, Beckman-Nahmias S. Sero-epidemiological and sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis 1990;69:19-36.
3. Oberle MW, Rosero-Bixby L, Lee FK, et al. Herpes simplex virus type 2 antibodies: High prevalence in monogamous women in Costa Rica. Am J Trop Med Hyg 1989;41:224-229.
4. Reichman RC, Badger GJ, Mertz GJ, et al. Treatment of recurrent genital herpes simplex infections with oral acyclovir: A controlled trial. J Am Med Assoc 1984;251:2103-2107.
5. Marchant J, Roe A. Genital herpes: Recognizing and addressing patients' needs. Herpes 1997;4:36-41.
6. Porco TC, Blower SM. Predicting and preventing the emergence of antiviral drug resistance in HSV-2. Nature Med 1998;4:673-678.
7. Blower SM, Hartel D, Dowlatabadi H, et al. Drugs, sex and HIV: A mathematical model for New York City. Phil Trans Roy Soc Series B 1991;321:171-187.
8. Blower SM, Dowlatabadi H. Sensitivity and uncertainty analysis of complex models of disease transmission: An HIV model, as an example. Int Stat Rev 1994;62:229-243.
9. Blower SM, McLean AR, Porco TC, et al. The intrinsic transmission dynamics of tuberculosis epidemics. Nature Med 1995;1:815-821.
10. Sanchez MA, Blower SM. Uncertainty and sensitivity analysis of the basic reproductive rate: Tuberculosis as an example. Am J Epidemiol 1997;145:1127-1138.
11. Proco TC, Blower SM. Quantifying the intrinsic transmission dynamics of tuberculosis. Theor Pop Biol 1998;54:117-132.
12. Lietman T, Porco T, Dawson C, Blower S. Global elimination of trachoma: how frequently should we administer mass chemotherapy? Nature Med 1999;5:572-576.
13. Wildy P, Field HJ, Nash AA. Classical herpes latency revisited. Soc Gen Microbiol Symp 1982;33:133-167.
14. Straus SE, Takiff HE, Seidlin M, et al. Suppression of frequently recurring genital herpes: A placebo-controlled double-blind trial of oral acyclovir. N Engl J Med 1984;310:1545-1550.
15. Collins P, Darby G. Laboratory studies of herpes simplex virus strains resistant to Acyclovir. Rev Med Virol 1991;1:19-28.
16. Blower SM, Small PM, Hopewell P. Control strategies for tuberculosis epidemics: New models for old problems. Science 1996;273:497-500.
17. Blower SM, Gerberding JL. Understanding, predicting and controlling the emergence of drug-resistant tuberculosis: A theoretical framework. J Mol Med 1998;76:624-636.
18. Blower S, Porco T, Lietman T. Tuberculosis: The evolution of antibiotic resistance and the design of epidemic control strategies. In: Horn MA, Simonett G, Webb G, eds. Mathematical models in medical and health sciences. Nashville, TN: Vanderbilt University Press, 1998, pp 514-72.
19. Blower S, Koelle K, Lietman T. Antibiotic resistance-to treat or not to treat. Nature Med 1999;5:358.
20. Mckay MD, Beckman RJ, Conover WJ. A comparison of three methods for selecting values of input variables in the analysis of output from a computer code. Technometrics 1979;21:239-245.
21. Iman RL, Helton JC. An investigation of uncertainty and sensitivity analysis techniques for computer models. Risk Anal 1980;8:71-90.
22. Blower SM, McLean AR. Prophylactic vaccines, risk behavior change and the probability of eradicating HIV in San Francisco. Science 1994;265:1451-1454.
23. Blower SM, Gershengorn HB, Grant RM. A tale of two futures: HIV and antiretroviral therapy in San Francisco. Science 2000;287:650-654.